Multiple sclerosis disease-modifying therapies: adverse effect surveillance and management.
about
Therapeutic decisions in multiple sclerosis: moving beyond efficacyEmerging oral treatments in multiple sclerosis - clinical utility of cladribine tabletsThe safety and efficacy of IFN-beta products for the treatment of multiple sclerosis.Injectable multiple sclerosis medications: a patient survey of factors associated with injection-site reactions.Advancing drug delivery systems for the treatment of multiple sclerosis.
P2860
Multiple sclerosis disease-modifying therapies: adverse effect surveillance and management.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Multiple sclerosis disease-mod ...... t surveillance and management.
@ast
Multiple sclerosis disease-mod ...... t surveillance and management.
@en
type
label
Multiple sclerosis disease-mod ...... t surveillance and management.
@ast
Multiple sclerosis disease-mod ...... t surveillance and management.
@en
prefLabel
Multiple sclerosis disease-mod ...... t surveillance and management.
@ast
Multiple sclerosis disease-mod ...... t surveillance and management.
@en
P2860
P356
P1476
Multiple sclerosis disease-mod ...... t surveillance and management.
@en
P2093
Dean M Wingerchuk
P2860
P304
P356
10.1586/14737175.6.3.333
P577
2006-03-01T00:00:00Z